PLIANT THERAPEUTICS, INC. (PLRX) AI Dilution Summary

Cash was $158,101,000 at the 2026-06-30 balance-sheet date, against estimated monthly burn of $4,265,667. The funding channel in place is an at-the-market program with Leerink Partners LLC, authorised to $50,000,000, with $0 sold to date. Dilution here is driven primarily by the S-3 shelf registration 333-294737.